Europe’s first psychedelic drug trial firm to open in London

psych_news
Written By Guest User

Startup Clerkenwell Health hopes to help make UK a world leader in psychedelics research

Guest User
Previous

MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders
Next

MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD